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Introduction
Sepsis is defined as a life-threatening organ dys-
function that is caused by a dysregulated host response
to infection.1 It is a common cause of admission to the
Emergency Department (ED), and it is essential to dif-
ferentiate sepsis from an uncomplicated infection be-
cause sepsis can lead to multiple organ dysfunction
syndrome and death. Early recognition of sepsis, ide-
ally in the pre-hospital phase or during triage, can im-
prove outcomes of these patients through
corresponding interventions, which include timely flu-
ids administration and appropriate antibiotics. How-
ever, because sepsis is a complex, heterogeneous
disease, it is often difficult for clinicians to promptly
identify patients with sepsis.2
There are no gold standard tests or diagnostic cri-
teria to detect patients with sepsis. For more than two
decades, the systemic inflammatory response syn-
drome (SIRS) criteria have been used in the diagnosis
of sepsis.3 Researchers in several studies have reported
controversies regarding the applicability of SIRS, and
the SIRS criteria have also been criticized as a sepsis
screening tool because of inadequate specificity and
sensitivity.4 In 2016, the Society of Critical Care Med-
icine/European Society of Intensive Care Medicine
task force released the Third International Consensus
Definitions for Sepsis and Septic Shock (Sepsis-3) as
a new definition for sepsis.5
Following this consensus statement, several stud-
ies tried to evaluate the prognostic value of SOFA and
of the simplified version qSOFA in comparison with
positive SIRS criteria for early identification of in-hos-
pital mortality in patients with suspected infection.6-9
Other authors suggest the use of modified early warn-
ing score (MEWS), although not sepsis-specific, for
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the early recognition of patient at risk of clinical dete-
rioration.10
Lactates and procalcitonin are the most validated
and the most commonly used biomarkers for diagnosis
and prognostic stratification of sepsis.11 The use of
qSOFA in association with the assessment of venous
lactates is suggested to increase qSOFA prognostic
performance and it is shown that a lactate level above
2 mmol/L is associated with a worse outcome in terms
of in-hospital mortality, admission to ICU and use of
vasopressors.11 Similarly, patients with severe sepsis,
septic shock and patients with sepsis that progresses
towards a poor outcome had higher values of PCT
compared to patients with a better prognosis.12
Aim of this study is to compare different tools
(qSOFA, SIRS, SOFA, and MEWS) for the early di-
agnosis and prognostic stratification of septic patients
arriving at the ED of San Luigi Gonzaga for sepsis.
Materials and Methods
A single-center study was performed: 510 patients
(1.1% of the annual census) who subsequently visited
the ED of San Luigi Gonzaga Orbassano (TO) from
May 2018 to March 2019 for infections were evalu-
ated. The study was approved by the Institutional Re-
view Board.
We included patients who were 18 years or older
and had a diffused infection of any severity, defined
both by sepsis definition scores and by a clinical cri-
teria, similarly to other studies.13,14 The inclusion cri-
teria were: i) patients that visited the ED with a suspect
of infection on a clinical or instrumental basis, asso-
ciated with signs of SIRS; ii) patients that were iden-
tified as septic according to clinical judgment.
Patients were included only once regardless of the
number of consultations at the ED. If patients con-
sulted the ED more than once with a probable infec-
tion, the first consultation was selected. We excluded
patients: i) who refused to participate; ii) with a low-
acuity infection, defined by a localized infection with-
out general symptoms and normal vital parameters;
iii) in whom the positivity of the SIRS or qSOFA cri-
teria is attributable in the first hypothesis to a non-in-
fectious event (i.e. trauma, CAD, Stroke, acute
pancreatitis). Patients who later needed surgical inter-
ventions, as part of their source control were included.
All data necessary for the SIRS (temperature, heart
rate, blood pressure, respiratory rate, PaCO2, leuko-
cytes), qSOFA (respiratory rate, systolic blood pressure,
GCS), SOFA (Glasgow coma scale, altered mentation,
blood pressure, respiratory rate, PaO2/FIO2, serum
thrombocytes, bilirubin, lactate and creatinine and the
use of vasopressor agents) and MEWS (respiratory rate,
heart rate, systolic blood pressure, temperature, con-
sciousness [Alert, Voice, Pain, Unconscious scale
(AVPU)], as well as general demographics such as age
and gender were collected. Moreover, data about labo-
ratory tests (lactates and procalcitonin assays) were col-
lected when present. All data were collected in the first
12 h from arrival. MEWS was collected upon arrival
from triage vitals; qSOFA was collected on arrival (t0),
6h from arrival (t6) and 12 h (t12) from arrival. This tim-
ing was chosen because the right time of qSOFA assess-
ment is still controversial. SOFA was calculated at 12 h
when laboratory tests were available.
Sepsis based on the SIRS criteria (Sepsis-1 defini-
tion) was defined as a probable infection combined
with a SIRS score of ≥2 points.9 Sepsis based on the
Sepsis-3 criteria was defined as infection with a SOFA
score ≥2 points from the baseline.1 Furthermore, we
assessed the use of qSOFA instead of SOFA in this
same definition, with the standard cut-off of qSOFA
≥2 points.1 MEWS ≥5 points was previously found to
be predictive of mortality in septic patients, thus we
applied the same cut-off.10 Lactate levels over 2 and
procalcitonin levels over 2 are considered biomarkers
of severe sepsis.11,12
The evaluation of the variables and the scores did
not interfere with the current clinical practice; the at-
tending physician was unaware of the results of the
scores calculated.1,9
We prospectively evaluated the following out-
comes: 30-day mortality, 60-day mortality and admis-
sion to a higher level of care wards [Intensive Care
Unit (ICU) and High Dependency Unit (HDU)]. Fur-
thermore, we evaluated secondary ICU/HDU admis-
sion (for deterioration of the clinical condition after
admission to the general ward). When a patient was
admitted both to ICU or to HDU we considered ad-
mission (primary or secondary) in high-level-of care
ward (ICU-adm). The decision for ICU/HDU admis-
sion followed the usual clinical practice, institutional
guidelines and local policies.
Outcomes were derived by reviewing the hospital
digital records and by a phone call to collect informa-
tion after discharge.
Data were described using means and standard de-
viations (SD) for continuous variables, medians and
interquartile ranges (IQR) for discrete variables, ab-
solute frequencies and percentages for categorical and
qualitative variables. The Shapiro-Wilk test15 was used
to test the normality of the distribution of quantitative
variables, and since most of the distributions violated
the normality assumption, non-parametric tests were
conducted. We evaluated the number of cases defined
as septic according to the different sepsis definitions.
We compared the results of the scores between sub-
groups of different outcomes (survivors vs non-sur-
vivors; admitted in ICU or HDU vs admitted in a
regular ward) using Wilcoxon rank sum test16 or Chi
square test,17 as appropriate.











Receiver operator characteristic (ROC) curves and
the area under the ROC curve (area under the curve
AUC) were calculated to determine how clinical scores
and biomarkers (qSOFA, SOFA, SIRS, lactates, and
procalcitonin) predict the primary endpoints. We calcu-
lated confidence interval at 95% (CI 95%) for all AUCs
to assess if the null hypothesis (AUC=0.50) was in-
cluded in the interval. De Long test was performed to
compare correlated ROC curves. For each combination
of clinical score and outcome parameter, sensitivity
(Se), specificity (Sp), positive predictive value (PPV),
negative predictive value (NPV), positive likelihood
ratio (LH+) and negative likelihood ratio (LH–) were
computed according to the standard cut-off. 
All tests were two-tailed and a P-value of 0.05 or
less was considered statistically significant.
All statistical analyses were carried out using SAS
Software Version 9.218 and R Version 3.5.2 (Eggshell
Igloo, 2018-12-20).19
Results
A total of 510 patients were enrolled during the re-
cruitment period. 41 patients were lost to follow up,
leaving 469 patients included for the final analysis. The
median age was 73 years (range: 61-81), 325 (69%) pa-
tients were older than 65 years. There were 267 (57%)
male patients and 202 (43%) female patients.
17% of patients were admitted to hospital for in-
fection in the month before the recruitment, 8% of pa-
tients were admitted for other reasons in the month
before the recruitment.
28% of our cohort was concurrently suffering from
neoplasm, 23% presented diabetes, 24% had heart fail-
ure or coronary artery disease (CAD) or stroke events
in the past and 13% of patients were immunosup-
pressed.
Baseline characteristics are summarized in Table 1. 
Among the data we collected, Respiratory Rate
was missing in nearly 10% of cases, thus we assume
that it was in the normal range for computing qSOFA
and MEWS at t0. The other variables in the study were
not affected by missing values except for lactates and
procalcitonin. 
At follow-up, all patients received antibiotic ther-
apy, 347 (74%) patients received fluid therapy, 12
(3%) patients in our cohort needed vasopressors ad-
ministration.
The overall admittance rate was 79% (371); in this
group, 68 patients were admitted to the ICU (4) or
HDU (64), respectively. 15 more patients were subse-
quently transferred to ICU for clinical deterioration
(Secondary ICU).
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Table 1. The results of the scores in the overall population and in the group of patients according to their outcome. Values
are expressed as median [interquartile range]. 
                                                               Overall                      Alive at 60 days                Dead at 60 days                            P
Age years                                             69.69±16.4                         67.4±16.7                         79.11±11.01                                 
                                                             73 [61-81]                         71 [57-80]                          80 [75-87]                            <0.001*
Gender M/F                                            267/202                             206/171                                61/31                                 0.048§
SIRS                                                        2 [1-3]                               2 [1-3]                                2 [1-3]                                 0.46*
SOFA                                                       2 [1-4]                               2 [1-3]                                4 [2-7]                               <0.001*
qSOFA t0                                                  1 [0-1]                               0 [0-1]                                1 [1-2]                               <0.001*
qSOFA t6                                                  0 [0-1]                               0 [0-1]                                1 [0-2]                               <0.001*
qSOFA t12                                                 0 [0-1]                               0 [0-1]                                1 [0-2]                               <0.001*
MEWS                                                     3 [1-4]                               2 [1-4]                              4 [1.5-5]                             0.0034*
Lactates mmol/L                                   2.26±2.33                              1.8±2                               3.27±2.8                                    
                                                             1.5 [1-2.5]                        1.4 [0.9-2.1]                         2.25 [1-5]                             0.005*
                                                               (n=141)                             (n=101)                               (n=40)
PCT ng/mL                                             5.37±14                             4.26±11                              10.3±23                                    
                                                          0.6 [0.18-3.29]                 0.49 [0.17-2.57]                 1.06 [0.23-7.03]                        0.038*
                                                               (n=302)                             (n=247)                               (n=55)
Recent (<1 month)                                114 (24%)                          93 (24%)                            21 (22%)                                   
hospitalization                                             78                                      63                                       15                                      0.7§
for infectionfor other causes                       36                                      30                                        6
n                                                                 469                                    377                                      92
Comparisons were made according to Wilcoxon rank sum test* and Chi square test §. P<0.05 are in italic. The number of cases (n) for lactates and procalcitonin (PCT) are reported











98 (21%) were discharged home or to outpatient
clinics from the ED.
In our sample, 92 patients (19.6%) died: 90 % of
them (83) died during their stay in the hospital, 14
(15%) died in the Emergency Department and 9 (10%)
patients died after being discharged from our hospital.
Examining the final ED diagnosis 451 patients
were defined by the ED physician as having sepsis, 18
patients as having septic shock.
We identified 325 patients (69%) as having sepsis
using the Sepsis-1 definition, and 292 patients (62%)
using the Sepsis-3 definition with SOFA≥2. Using the
qSOFA, 89 (19%) fulfilled the definition criteria at the
time of arrival (t0), 69 (15%) after 6 hours (t6) and 62
(13%) after 12 hours (t12). Considering the highest one
out of the three qSOFA (qSOFA Overall), 123 patients
(26%) fulfilled the definition criteria. A total of 72 pa-
tients (16%) were not picked up by any criteria.
Sepsis-related organ dysfunction according to the
Sepsis-1 criteria was present in 127 patients out of 325
patients (39%). 
Only 21 patients (4%) presented with septic shock
according to the Sepsis-1 definition, and 13 patients
(3%) presented with septic shock according to the
Sepsis-3 definitions.
The relationship between study groups according
to Sepsis-1 and Sepsis-3 definitions are illustrated
graphically in Figure 1.
Median MEWS was 3 [IQR 1-4], with 87 (18%)
patients of our sample over the standard cut-off
(MEWS ≥5).10
Serum lactates were assessed in 141 (30%) pa-
tients, out of them only 52 (37%) patients had a lactate
measurement ≥2 mmol/L.11
Procalcitonin was assessed in 302 (64%) patients,
out of them only 98 (32%) had a procalcitonin meas-
urement ≥2 ng/mL.12
Afterwards we evaluated the prognostic value of
the scores with regards to the outcomes.
Mortality
Thirty- and 60-day mortalities were 15.8 % (74)
and 19.6% (92), respectively. Patients who died were
significantly older and got statistically significant
higher qSOFA, SOFA and MEWS scores compared to
patients who survived. Conversely, SIRS score did not
show a statistically significant difference between
non-survivors and survivors’ groups, as shown in
Table 1. Lactates levels were significantly higher in
patients who died in comparison with the ones that
survived; a similar trend was shown for procalcitonin
although it did not reach the statistical significance.
An AUC curve for the prediction of death/ mortal-
ity was constructed with new and former definitions
of sepsis, namely SOFA, qSOFA, SIRS, MEWS, lac-
tates and procalcitonin measurements. The highest
AUCs were for the SOFA score [30 days 0.76 (0.69-
0.81); 60 days 0.74 (0.68-0.79)] and qSOFA score [30
days 0.72 (0.65-0.79); 60 days 0.73 (0.66-0.78)] fol-
lowed by lactates [30 days 0.71 (0.60-0.82); 60 days
0.65 (0.54-0.76)] as shown in Figure 2.
Prognostic performances of SOFA, qSOFA, SIRS,
MEWS, lactates and procalcitonin according to the
standard cut-offs to predict 30- and 60-day mortality
are reported in Table 2.
Comparison of ROC curves showed that the per-
formance of qSOFA and SOFA was not significantly
different for the prediction of mortality at 30 and 60
days (P=0.34 and P=0.76 respectively); both performed
significantly better than SIRS (qSOFA at 30 d and 60 d
P<0.001, SOFA at 30 d and 60 d P<0.001). MEWS was
significantly superior to SIRS (P=0.01 at 30 d and
P<0.01 at 60 d) but inferior to SOFA (P<0.001 at 30 d
and 60 d) and qSOFA (P<0.001 at 30 d and 60 d).
Table 2 shows the characteristics of the scores for
the prediction of 30-day and 60-day mortality. Se, Sp,
PPV, NPV, LH+, and LH– were calculated for the ex-
isting cut-offs. 
Intensive Care Unit/High Dependence Unit
admission
A total of 68 patients (14.5%) of our cohort were
admitted to the Intensive Care Unit or High Depend-
ency Unit, while 15 (3%) were admitted to the Inten-
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Figure 1. It describes graphically the proportion of pa-
tients included in each diagnostic definition of sepsis ac-
cording to the different scores. Sepsis based on the SIRS
criteria (Sepsis-1)3 was defined as a probable infection
combined with a SIRS score of ≥2 points (in black). Sep-
sis based on the Sepsis-3 criteria1 was defined as infec-
tion with a SOFA score ≥2 points (in grey) and a qSOFA










sive Care Unit or High Dependency Unit after a me-
dian of 9 days in a general ward (secondary ICU ad-
mission).
SOFA, qSOFA score at t12, procalcitonin and
MEWS score were statistically significant predictors
of ICU/HDU admission, showing higher values in
ICU patients. Details are described in Table 3.
Procalcitonin, SOFA and MEWS were the only ef-
fective predictors of ICU admission with the following
AUC: PCT 0.66 (0.56-0.64), MEWS 0.60 (0.53-0.67)
and SOFA 0.61 (0.54-0.69), respectively (details in
Table 2).
In the supplementary material, the ROC curves for
each parameter included in the study are represented
and described individually for each outcome.
Table 2 shows the characteristics of the scores for
the prediction of ICU admission. Se, Sp, PPV, NPV,
LH+, and LH– were calculated for the existing cut-offs.
Discussion
Sepsis is a systemic disease with variable clinical
presentations but without a gold standard for a defin-
itive diagnosis. This prospective study included pa-
tients with suspected infection of all severities and
considered outcomes in the short and medium term,
aiming to find the best tool for the early diagnosis and
prognostic stratification of septic patients in the ED.
Sepsis-1 criteria,9 namely the presence of 2 or
more SIRS criteria associated with infection, identi-
fied most patients in the at-risk population (69%), fol-
lowed by Sepsis-31 (namely SOFA of 2 or more)
(62%). The use of qSOFA dramatically reduced the
number of patients classified as septic (26%). There
was a partial overlap between the diagnostic criteria,
with half of the septic patients identified by both SIRS
and SOFA and half of the patients that are classified
in the same category by SOFA and qSOFA. Many
cases showed discordant results at the three scoring
systems, similarly to previous studies.20
These results confirmed that scores have limita-
tions in diagnosing this complex heterogeneous situ-
ation as sepsis is: SIRS criteria are more sensitive,
SOFA is a complete and specific tool and qSOFA is
easy to perform but is not completely concordant with
SOFA. Moreover, we lack a gold standard to compare
the scores with: we used clinical diagnosis at the end
of ED stay and antibiotic administration to confirm
that our population was defined as septic.
On the other hand, the most recent sepsis defini-
tion and guidelines (Sepsis-3)1 strongly focus on iden-
tifying patients with a poor prognosis and suggest the
use of scores for risk stratification in order to select
candidates for early intensive treatment. SOFA,
qSOFA and lactates levels confirmed to be accurate in
predicting mortality. Our population showed a mortal-
ity rate of nearly 19%, in line with other studies in dif-
ferent countries.21,22 Having an elevated SOFA,
qSOFA, MEWS score, elevated lactates, and procal-
citonin levels it was related to a worse prognosis.
SOFA, qSOFA and MEWS were found to be accurate,
with qSOFA being the most specific and SOFA the
most sensitive tools. Small differences in sensitivity
and specificity were observed when comparing the
characteristics of the tools to evaluate short-term and
medium-term mortality. While SOFA was confirmed
to be like SIRS in patient identification and superior
to SIRS5,22-24 in prediction of mortality outcome, it re-
quires complete blood test analysis. SOFA’s variables
could be unavailable in specific settings and this could
create delays in patient treatment. The prospective na-
ture of our study, in this respect, was useful to avoid
missing data.
qSOFA is simplified in comparison with SOFA,
but in 9 to 51% of cases23 is described to suffer from
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Figure 2. It compares, for each of the outcomes in the study, the ROC curves for the parameters included in study.
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Table 2. The characteristics of the scores for the outcome mortality at 30 and 60 days and for Intensive Care Unit ad-
mission. 
                                                        Outcome death 30 days                 Outcome death 60 days                 ICU admission
SIRS                                                Se 0.76 (0.64, 0.85)                         Se 0.74 (0.64, 0.83)                         Se 0.75 (0.63, 0.85)
                                                        Sp 0.32 (0.27, 0.36)                         Sp 0.32 (0.27, 0.37)                         Sp 0.32 (0.27, 0.36)
                                                        PPV 0.17 (0.13, 0.22)                      PPV 0.21 (0.17, 0.26)                      PPV 0.16 (0.12, 0.20)
                                                        NPV 0.87 (0.81, 0.92)                     NPV 0.83 (0.76, 0.89)                     NPV 0.88 (0.82, 0.93)
                                                        LH+ 1.11 (0.96, 1.28)                      LH+ 1.08 (0.94, 1.24)                      LH+ 1.09 (0.94, 1.28)
                                                        LH- 0.77 (0.50, 1.18)                      LH- 0.83 (0.57, 1.20)                      LH- 0.79 (0.51, 1.23)
                                                        AUC 0.535 (0.467, 0.603)               AUC 0.524 (0.461, 0.587)               AUC 0.548 (0.476, 0.619)
                                                        Cut-off 2                                          Cut-off 2                                          Cut-off 2
SOFA                                               Se 0.91 (0.81, 0.96)                         Se 0.86 (0.77, 0.92)                         Se 0.74 (0.61, 0.83)
                                                        Sp 0.43 (0.38, 0.48)                         Sp 0.43 (0.38, 0.49)                         Sp 0.40 (0.35, 0.44)
                                                        PPV 0.23 (0.18, 0.28)                      PPV 0.27 (0.22, 0.33)                      PPV 0.17 (0.13, 0.22)
                                                        NPV 0.96 (0.92, 0.98)                     NPV 0.93 (0.88, 0.96)                     NPV 0.90 (0.84, 0.94)
                                                        LH+ 1.59 (1.42, 1.77)                      LH+ 1.52 (1.34, 1.71)                      LH+ 1.22 (1.03, 1.43)
                                                        LH- 0.22 (0.11, 0.45)                       LH- 0.33 (0.19, 0.55)                      LH- 0.67 (0.44, 1.01)
                                                        AUC 0.758 (0.699, 0.816)               AUC 0.738 (0.681, 0.795)               AUC 0.617 (0.541, 0.692)
                                                        Cut-off 2                                          Cut-off 2                                          Cut-off 2
qSOFA t0                                          Se 0.50 (0.38, 0.62)                         Se 0.48 (0.37, 0.58)                         Se 0.19 (0.11, 0.30)
                                                        Sp 0.87 (0.83, 0.90)                         Sp 0.88 (0.85, 0.91)                         Sp 0.81 (0.77, 0.85)
                                                        PPV 0.42 (0.32, 0.53)                      PPV 0.50 (0.39, 0.61)                      PPV 0.15 (0.08, 0.24)
                                                        NPV 0.90 (0.87, 0.93)                     NPV 0.87 (0.84, 0.91)                     NPV 0.86 (0.82, 0.89)
                                                        LH+ 3.87 (2.75, 5.46)                      LH+ 4.10 (2.89, 5.82)                      LH+ 1.03 (0.61, 1.76)
                                                        LH- 0.57 (0.46, 0.72)                      LH- 0.59 (0.48, 0.72)                      LH- 0.99 (0.88, 1.12)
                                                        AUC 0.725 (0.659, 0.79)                 AUC 0.728 (0.669, 0.786)               AUC 0.558 (0.492, 0.625)
                                                        Cut-off 2                                          Cut-off 2                                          Cut-off 2
qSOFA t6                                          Se 0.43 (0.31, 0.56)                         Se 0.39 (0.29, 0.51)                         Se 0.26 (0.16, 0.39)
                                                        Sp 0.89 (0.85, 0.92)                         Sp 0.90 (0.86, 0.93)                         Sp 0.86 (0.82, 0.89)
                                                        PPV 0.43 (0.31, 0.55)                      PPV 0.49 (0.36, 0.61)                      PPV 0.24 (0.14, 0.36)
                                                        NPV 0.89 (0.86, 0.92)                     NePV 0.86 (0.82, 0.89)                   NPV 0.87 (0.83, 0.91)
                                                        LH+ 3.95 (2.64, 5.92)                      LH+ 3.81 (2.52, 5.74)                      LH+ 1.86 (1.14, 3.04)
                                                        LH- 0.64 (0.52, 0.79)                      LH- 0.68 (0.57, 0.81)                      LH- 0.86 (0.74, 1.00)
                                                        AUC 0.712 (0.642, 0.782)               AUC 0.714 (0.652, 0.775)               AUC 0.576 (0.501, 0.651)
                                                        Cut-off 2                                          Cut-off 2                                          Cut-off 2
qSOFA t12                                         Se 0.46 (0.33, 0.59)                         Se 0.40 (0.29, 0.52)                         Se 0.23 (0.13, 0.36)
                                                        Sp 0.91 (0.87, 0.94)                         Sp 0.92 (0.88, 0.94)                         Sp 0.87 (0.83, 0.90)
                                                        PPV 0.48 (0.35, 0.62)                      PPV 0.53 (0.40, 0.67)                      PPV 0.23 (0.13, 0.36)
                                                        NPV 0.90 (0.87, 0.93)                     NPV 0.86 (0.82, 0.90)                     NPV 0.87 (0.83, 0.91)
                                                        LH+ 5.11 (3.30, 7.91)                      LH+ 4.74 (3.02, 7.45)                      LH+ 1.78 (1.03, 3.09)
                                                        LH- 0.59 (0.47, 0.75)                      LH- 0.65 (0.54, 0.79)                      LH- 0.88 (0.76, 1.03)
                                                        AUC 0.698 (0.621, 0.775)               AUC 0.693 (0.625, 0.761)               AUC 0.592 (0.516, 0.669)
                                                        Cut-off 2                                          Cut-off 2                                          Cut-off 2
MEWS                                             Se 0.35 (0.24, 0.47)                         Se 0.34 (0.24, 0.44)                         Se 0.25 (0.15, 0.37)
                                                        Sp 0.85 (0.81, 0.88)                         Sp 0.85 (0.81, 0.89)                         Sp 0.82 (0.78, 0.86)
                                                        PPV 0.30 (0.21, 0.41)                      PPV 0.36 (0.26, 0.47)                      PPV 0.20 (0.12, 0.29)
                                                        NPV 0.87 (0.84, 0.91)                     NPV 0.84 (0.80, 0.88)                     NPV 0.87 (0.83, 0.90)
                                                        LH+ 2.28 (1.55, 3.35)                      LH+ 2.27 (1.56, 3.30)                      LH+ 1.43 (0.90, 2.27)
                                                        LH- 0.77 (0.65, 0.91)                      LH- 0.78 (0.67, 0.91)                      LH- 0.91 (0.79, 1.05)
                                                        AUC 0.61 (0.533, 0.687)                 AUC 0.597 (0.526, 0.667)               AUC 0.604 (0.534, 0.674)
                                                        Cut-off 5                                          Cut-off 5                                          Cut-off 5
Lactates (n=141)                              Se 0.62 (0.44, 0.78)                         Se 0.55 (0.38, 0.71)                         Se 0.48 (0.30, 0.67)
                                                        Sp 0.71 (0.61, 0.79)                         Sp 0.70 (0.60, 0.79)                         Sp 0.66 (0.57, 0.75)
                                                        PPV 0.40 (0.27, 0.55)                      PPV 0.42 (0.29, 0.57)                      PPV 0.29 (0.17, 0.43)
                                                        NPV 0.85 (0.76, 0.92)                     NPV 0.80 (0.70, 0.88)                     NPV 0.82 (0.72, 0.89)
                                                        LH+ 2.13 (1.43, 3.17)                      LH+ 1.85 (1.23, 2.79)                      LH+ 1.44 (0.92, 2.25)
                                                        LH- 0.54 (0.35, 0.84)                      LH- 0.64 (0.44, 0.92)                      LH- 0.78 (0.54, 1.12)
                                                        AUC 0.717 (0.607, 0.826)               AUC 0.652 (0.54, 0.763)                 AUC 0.577 (0.464, 0.69)
                                                        Cut-off 2                                          Cut-off 2                                          Cut-off 2
PCT (n=302)                                    Se 0.40 (0.25, 0.56)                         Se 0.38 (0.25, 0.52)                         Se 0.60 (0.45, 0.74)
                                                        Sp 0.69 (0.63, 0.74)                         Sp 0.69 (0.63, 0.75)                         Sp 0.73 (0.67, 0.78)
                                                        PPV 0.17 (0.10, 0.26)                      PPV 0.21 (0.14, 0.31)                      PPV 0.30 (0.21, 0.40)
                                                        NPV 0.87 (0.82, 0.92)                     NPV 0.83 (0.77, 0.88)                     NPV 0.91 (0.86, 0.94)
                                                        LH+ 1.26 (0.84, 1.91)                      LH+ 1.22 (0.83, 1.80)                      LH+ 2.22 (1.64, 3.02)
                                                        LH- 0.88 (0.68, 1.14)                      LH- 0.90 (0.72, 1.12)                      LH- 0.54 (0.38, 0.78)
                                                        AUC 0.605 (0.512, 0.698)               AUC 0.589 (0.505, 0.674)               AUC 0.656 (0.564, 0.748)
                                                        Cut-off 2                                          Cut-off 2                                          Cut-off 2
Sensitivity (Se), specificity (Sp), Positive and negative predictive value (PPV and NPV) and Positive and negative likelihood ratio (LH+ and LH-) are calculated for the existing cut-
off. Area Under the Curve is displayed. Confidence interval at 95% (CI95%) is described in brackets. SIRS, systemic inflammatory response syndrome; SOFA, sequential organ










missing pieces of information about the neurological
status and from the absence of the record for respira-
tory rate. When no report was found on the respiratory
status (less than 10% of cases) we assigned the normal
score to the item, similarly to previous studies. We
found information about neurological status in all the
patients. In our study qSOFA was more specific but
less sensitive than SOFA for all the outcomes but per-
formed equally well.
The simplified qSOFA which was proposed for
bedside use in the ED is suggested to be repeated and
considered by its variance in time.1 In our study
qSOFA was calculated upon arrival and after 6 and 12
h: the accuracy of qSOFA in predicting mortality was
similar upon arrival and in the following serial inter-
vals; the accuracy in predicting mortality and ICU ad-
mission increased in serial measurements. In this
setting, serial qSOFA could be used to evaluate the dy-
namic and evolving characteristics of sepsis, in accor-
dance with other authors findings.23
These results are in line with other studies per-
formed in ICU, general wards and ED settings in Eu-
rope, USA, Africa and Australia20,24-26 and with a
recent meta-analysis.27
Most patients of our population were admitted,
less than 20% of admissions were to ICU or HDU
units, with an additional 3% of patients admitted to a
regular ward and then transferred to intensive care unit
for physiological deterioration. Globally the accuracy
of the scores was lower in predicting the need for in-
tensive care, but this result could be biased by the low
number of cases. Moreover, ICU admittance is af-
fected by age and co-morbid conditions (like DNR sta-
tus) and it is not only determined by sepsis severity.
MEWS was not originally designed for recogni-
tion of sepsis patients and is meant to evaluate the
evolving severity of any illness, not only sepsis.10,28,29
We do not support the use of MEWS alone for the di-
agnosis of sepsis, but our data support its use in se-
lecting patients that will need ICU admission. 
Procalcitonin, as a marker of the most serious in-
fections, has a role in evaluating the burden of the dis-
ease and the ICU admission, and should be used in
association with the above-described scores. Although
a perfect diagnostic tool is a pure utopia and all the
studies on septic patients are biased by the lack of a
gold standard, the inclusion in any definition proved
again to be reductive for a complex and pleomorphic
syndrome where the clinical gestalt associated with
some diagnostic tests is probably still the best deci-
sion-making pathway. 
We chose to evaluate outcomes that are crucial for
the decision process in the ED and that are under the
direct responsibility of the Emergency Physician in the
first 12 h from arrival: short term mortality, admission
to a high level of care wards (both ICU and HDU).
Medium-term mortality is partially related to the
global burden of sepsis on functional disability in
short-term survivors that can lead to further illnesses,
further hospitalizations and long-term death. This can
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Table 3. Median values of the scores in patients admitted to Intensive Care Unit and High Dependency Unit (ICU), ad-
mitted to the regular ward and admitted to ICU after the deterioration of clinical conditions during hospitalization (sec-
ondary ICU). 
                                                 Overall                                                  Admitted (n=371)                    
                                                                                ICU admitted            Regular ward          Secondary ICU                      P
Age                                         69.69±16.4                    68.4±14                     69.9±16.8                     71.2±15                             
                                               73 [61-81]                   73 [58-79]                   74 [62-82]                  77 [63-81]                        0.18
SIRS                                           2 [1-3]                       2 [1.5-3]                       2 [1-3]                        1 [1-3]                            0.2
qSOFA t0                                    1 [0-1]                         1 [0-2]                         0 [0-1]                        1 [0-2]                           0.13
qSOFA t6                                    0 [0-1]                         1 [0-2]                         0 [0-1]                        0 [0-1]                           0.06
qSOFA t12                                   0 [0-1]                         1 [0-1]                         0 [0-1]                        0 [0-1]                          0.029
SOFA                                         2 [1-4]                         3 [1-6]                         2 [1-4]                        3 [1-5]                          0.002
MEWS                                       3 [1-4]                       4 [2-4.5]                       2 [1-4]                        1 [0-3]                         0.0056
Lactatesmmol/L                      2.26±2.33                      2.5±2.2                       2.2±2.3                        1.68±2                              
                                               1.5 [1-2.5]                  51.8 [1.1-3]                1.5 [0.0-2.4]              0.75 [0.6-2.3]                      0.19
                                                 (n=141)                        (n=31)                        (n=110)                        (n=6)
PCT ng/mL                               5.37±14                     9.56±19.4                     4.57±13                     2.46±4.3                             
                                            0.6 [0.18-3.29]          3.78 [0.35 -9.19]         0.49 [0.16-2.24]          0.6 [0.23-2.15]                   0.0006
                                                 (n=302)                        (n=48)                        (n=254)                       (n=11)
n                                                    469                               68                               303                              15
Comparisons were made according to Wilcoxon rank sum test for both primary and secondary ICU admission. P<0.05 are in italic. Number of cases (n) in brackets. SIRS, systemic










explain the small differences in the performance of the
scores in evaluating the two mortality outcomes; any-
way, more data are needed to infer on this subject.
Strengths and limitations
The main strength of our study is its prospective
nature, that was useful in reducing the risk of missing
data that limited the validity of previous retrospective
assessments of SIRS, qSOFA and SOFA.
Secondly, we calculate qSOFA three times rather
than once as in previous studies. The repeated measure-
ments of qSOFA followed the ideal characteristics of a
screening tool for sepsis, where case discrimination
needs to be a continuous process and cannot be decided
by a single evaluation. This method was also useful to
test the better timing interval for using qSOFA, a rela-
tively new and still not routinely used tool.
Another strength is the inclusion of nearly all in-
fected patients that arrived in our ED in a large com-
plete dataset, not restricted to ICU patients, with a very
low rate of drop out.
Moreover, this study was based on clinical data in-
stead of administrative data and this real-world sample
results were like other previous studies on the subject.
On the other hand, the first limitation is the defi-
nition of the study population. As there is no gold stan-
dard for defining sepsis, the study population was
difficult to be determined. We included patients who
visited the ED with a suspect of infection associated
with signs of the SIRS, which could lead to a bias
when evaluating and comparing SIRS with the other
tools; we also included patients identified as septic ac-
cording to clinical judgment.
Another limitation is that lactates and procalci-
tonin levels were assessed only in nearly half of pa-
tients, due to the relative novelty of the availability of
the procalcitonin assay around the clock in our hospi-
tal and of the blood gas analyzer in our ED. The im-
plementation of the protocol increased clinician
awareness and in the final phase, the number of lac-
tates and procalcitonin essays was higher.
Another limitation is the small number of patients
admitted to the ICU, mainly due to the seniority of our
population.
Conclusions
In our opinion, SOFA remains the most complete
tool for the quick prognostic stratification and a more
precise estimate of the individual risk assessment.
SOFA, or alternatively qSOFA and lactates, in associa-
tion with procalcitonin assessment could guide man-
agement decisions: to start early goal-directed therapy
and to admit patients to a high level of care ward, if ap-
propriate, with the aim to improve patient’s outcome. 
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